Summary
Donald Trump announced a new tariff plan for generic drugs, offering a two-year tariff-free period followed by 100% and then 200% tariffs. This plan allows Indian exporters time to reassess supply chains but could significantly impact the economics of supplying generic medicines to the US without local production.